FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Savarese John

2. Date of Event Requiring Statement (MM/DD/YYYY)
10/31/2008 

3. Issuer Name and Ticker or Trading Symbol

MAKO Surgical Corp. [MAKO]

(Last)        (First)        (Middle)

3000 SAND HILL ROAD, BUILDING #1, SUITE 260

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

MENLO PARK, CA 94025       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   1623876   I   By Montreux Equity Partners IV, L.P.   (1)
Common Stock   114695   I   By Montreux IV Associates, L.L.C.   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrants (right to buy)   4/29/2009   11/2/2015   Common Stock   324775   $7.44   I   By Montreux Equity Partners IV, L.P.   (1)
Common Stock Warrants (right to buy)   4/29/2009   11/2/2015   Common Stock   22939   $7.44   I   By Montreux IV Associates, L.L.C.   (2)
Common Stock Warrants (right to buy)     (3)   (4) Common Stock   95382   $6.20   I   By Montreux Equity Partners IV, L.P.   (1)
Common Stock Warrants (right to buy)     (3)   (4) Common Stock   6737   $6.20   I   By Montreux IV Associates, L.L.C.   (2)

Explanation of Responses:
( 1)  The reporting person is a managing member of Montreux Equity Management IV, LLC, the general partner of Montreux Equity Partners IV, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecunairy interest therein.
( 2)  The reporting person is a managing member of Montreux Equity Management IV, LLC, which is the manager of Montreux IV Associates, L.L.C., but he disclaims beneficial ownership of the shares except to the extent of his pecunairy interest therein.
( 3)  The Warrants are exercisable at any time or times on or after the earlier of (i) December 31, 2009, or (ii) the purchase of additional shares of the issuer's common stock by the purchasers affiliated with the reporting person, which purchase may occur at the sole option of the issuer on or before December 31, 2009, following achievement of certain commercialization milestones.
( 4)  The Warrants will expire eighty-four (84) months from the date that the Warrants become exercisable. If such date falls on a day other than a business day, the expiration date will be the next business day.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Savarese John
3000 SAND HILL ROAD
BUILDING #1, SUITE 260
MENLO PARK, CA 94025
X



Signatures
/s/John Savarese, MD 11/10/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Mako Surgical Corp. (MM) Charts.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Mako Surgical Corp. (MM) Charts.